| [1] |
CHEN Weixin.
Analysis of the immune characteristics of peripheral blood lymphocyte subsets in patients with early and advanced non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2026, 46(6): 823-829.
|
| [2] |
LIU Pengpeng, SUN Zhao, QIU Wei, TANG Hui, ZHU Wenjia, WANG Wenhui, WANG Yingyi.
Impact of local radiotherapy on tyrosine kinase inhibitor treatment in non-small cell lung cancer with oligo-residual disease
[J]. Basic & Clinical Medicine, 2026, 46(4): 491-497.
|
| [3] |
ZHANG Zhen, YANG Lianren, HU Junkun, ZHANG Wei, LIANG Wei.
Value of serum D-dimer in evaluating chemotherapy effect and prognosis in patients with non-small cell lung cancer
[J]. Basic & Clinical Medicine, 2026, 46(3): 417-420.
|
| [4] |
LI Zhitao, BU Xuefeng, ZHANG Yongjun, MENG Nana, XIA Leizhou.
Farnesoid X receptor suppresses pancreatic cancer cell proliferation through negative regulation of matrix metalloproteinase 7
[J]. Basic & Clinical Medicine, 2026, 46(2): 250-255.
|
| [5] |
HUANG Qianqian, JIA Yufang, YU Huajun,CHEN Rongrong,CHEN Lili, WU Jun, ZHANG Haitao.
Stable knockout of ACSS3 in lung cancer cell line using CRISPR/Cas 9 technology
[J]. Basic & Clinical Medicine, 2025, 45(8): 1016-1021.
|
| [6] |
CHEN Lei,REN Weihao,WANG Lide.
Knockdown of translocase of inner mitochondrial membrane 8A enhances gefitinib sensitivity to lung cancer cell line PC-9
[J]. Basic & Clinical Medicine, 2025, 45(8): 1073-1077.
|
| [7] |
YANG Rui, DU Sifen, JIANG Lehui, FU Tian, REN Pengju, JIANG Chengyu, ZHANG Yanli.
Network pharmacology-based screening and validation of tea-derived small molecules against lung cancer
[J]. Basic & Clinical Medicine, 2025, 45(7): 939-946.
|
| [8] |
LOU Haijun, TONG Zhuoyun, ZHANG Zhenyu, Aheyerk·MAHESHATI, MENG·Menggen, WUDU Muli.
Knockdown of DRAM2 inhibits the proliferation and migration of lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2025, 45(2): 197-202.
|
| [9] |
ZHANG Yao, ZHANG Xuan, JIA Anna, ZHAN Shijia, GUO Jinxin, CHANG Yan, GUO Yongli.
Olfactory domain family protein 3 promotes the proliferation of MYCN-amplified neuroblastoma cell lines in vitro
[J]. Basic & Clinical Medicine, 2025, 45(2): 168-175.
|
| [10] |
YAO Anjun, CHEN Lingzi, JIN Huixian.
Docosahexaenoic acid inhibits proliferation of human colon cancer cell line HT-29
[J]. Basic & Clinical Medicine, 2024, 44(8): 1107-1112.
|
| [11] |
ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan.
Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.
|
| [12] |
CAO Qingwen, QI Lin, YU Bo, TIAN Chenchen, YUAN Haining, WANG Yue.
Salidroside promotes proliferation and migration of human vascular endothelial cell line EA.hy926
[J]. Basic & Clinical Medicine, 2024, 44(7): 925-930.
|
| [13] |
ZHANG Pengju, LI Jie, ZHANG Mengdi, SUN Shaoke, XU Yinzhe.
KAT8 promotes the proliferation of colorectal cancer cell lines by enhancing METTL3 expression
[J]. Basic & Clinical Medicine, 2024, 44(7): 931-939.
|
| [14] |
GAO Yinjie, TONG Anli.
Mechanisms of cell death and proliferation of aldosterone-producing adenoma
[J]. Basic & Clinical Medicine, 2024, 44(6): 758-762.
|
| [15] |
CAO Chenxin, TANG Hui, GENG Ruixuan, GUO Fuping, BAI Chunmei, WANG Yingyi, LI Taisheng.
Correlation between circulating CD4+CD45RA+CD62L+ T cells and prognosis of metastatic non-small cell lung cancer treated with EGFR-TKI
[J]. Basic & Clinical Medicine, 2024, 44(5): 658-664.
|